AGP Limited: Profits Surge in Second Quarter of 2025
AGP Limited (AGP), one of Pakistan’s major pharmaceutical companies, is set to announce impressive results for the second quarter of 2025 (April–June).
Are Pharma Stocks in Pakistan Poised for a Rerating?
After years of navigating tight price controls, rising costs, and volatile exchange rates, Pakistan’s pharmaceutical sector appears to be at a critical inflection point. Thanks...
AGP Limited: Earnings Strong, But Seasonal Dip Ahead
AGP Limited (AGP), one of Pakistan’s top pharmaceutical companies, is expected to show strong profits for the second quarter of 2025 (April–June), but a slight...
Top 3 sectors to trade in according to analysts
Wondering where the research houses want their clients to put their money in? If you are a trader and looking to maximize your gains
Why pharma exports could be Pakistan’s next billion-dollar opportunity?
Pakistan’s pharmaceutical industry has been on an upward trajectory thanks to deregulation, margin expansion, and a rising domestic market. But a far less discussed, and...
5 Reasons AGP Limited Could Be Your Next Big Pharma Pick
As Pakistan's pharmaceutical sector evolves rapidly post-deregulation, AGP Limited (AGP) stands out as one of the most attractive investment opportunities. With a strong product mix,...
Pharma Stock Valuations Are at a Discount, Is Now the Time to Buy?
Pakistan’s pharmaceutical sector has quietly morphed into a compelling value play. Despite major regulatory relief, margin expansion, and earnings growth, valuations across the board remain...
Can Pakistan’s local drugmakers outperform multinationals?
Pakistan’s pharmaceutical sector has entered a phase of structural transformation, and one question stands out: Can local drug manufacturers truly outperform multinational companies (MNCs)? Based...